This company has been marked as potentially delisted and may not be actively trading. Histogenics (HSGX) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock HSGX vs. SMTI, INGN, LAKE, AVR, ZJYL, MLSS, NTRB, APT, SPAI, and RBOTShould you be buying Histogenics stock or one of its competitors? The main competitors of Histogenics include Sanara MedTech (SMTI), Inogen (INGN), Lakeland Industries (LAKE), Anteris Technologies Global (AVR), Jin Medical International (ZJYL), Milestone Scientific (MLSS), Nutriband (NTRB), Alpha Pro Tech (APT), Safe Pro Group Inc. Common Stock (SPAI), and Vicarious Surgical (RBOT). Histogenics vs. Sanara MedTech Inogen Lakeland Industries Anteris Technologies Global Jin Medical International Milestone Scientific Nutriband Alpha Pro Tech Safe Pro Group Inc. Common Stock Vicarious Surgical Sanara MedTech (NASDAQ:SMTI) and Histogenics (NASDAQ:HSGX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership. Does the MarketBeat Community prefer SMTI or HSGX? Histogenics received 336 more outperform votes than Sanara MedTech when rated by MarketBeat users. Likewise, 71.66% of users gave Histogenics an outperform vote while only 60.53% of users gave Sanara MedTech an outperform vote. CompanyUnderperformOutperformSanara MedTechOutperform Votes2360.53% Underperform Votes1539.47% HistogenicsOutperform Votes35971.66% Underperform Votes14228.34% Do analysts prefer SMTI or HSGX? Sanara MedTech currently has a consensus target price of $48.50, suggesting a potential upside of 66.95%. Given Sanara MedTech's stronger consensus rating and higher probable upside, equities analysts plainly believe Sanara MedTech is more favorable than Histogenics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Histogenics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is SMTI or HSGX more profitable? Histogenics has a net margin of 0.00% compared to Sanara MedTech's net margin of -10.71%. Sanara MedTech's return on equity of -19.86% beat Histogenics' return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.71% -19.86% -10.91% Histogenics N/A -34.96%18.40% Do insiders and institutionals hold more shares of SMTI or HSGX? 8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 40.4% of Histogenics shares are owned by institutional investors. 54.1% of Sanara MedTech shares are owned by company insiders. Comparatively, 19.7% of Histogenics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the media refer more to SMTI or HSGX? In the previous week, Sanara MedTech had 2 more articles in the media than Histogenics. MarketBeat recorded 2 mentions for Sanara MedTech and 0 mentions for Histogenics. Sanara MedTech's average media sentiment score of 0.96 beat Histogenics' score of 0.00 indicating that Sanara MedTech is being referred to more favorably in the media. Company Overall Sentiment Sanara MedTech Positive Histogenics Neutral Which has stronger earnings & valuation, SMTI or HSGX? Sanara MedTech has higher revenue and earnings than Histogenics. Sanara MedTech is trading at a lower price-to-earnings ratio than Histogenics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$86.67M2.98-$4.30M-$1.14-25.48HistogenicsN/AN/A-$8.64M-$0.79-0.87 Which has more risk and volatility, SMTI or HSGX? Sanara MedTech has a beta of 1.47, suggesting that its share price is 47% more volatile than the S&P 500. Comparatively, Histogenics has a beta of 3.1, suggesting that its share price is 210% more volatile than the S&P 500. SummarySanara MedTech beats Histogenics on 9 of the 17 factors compared between the two stocks. Remove Ads Get Histogenics News Delivered to You Automatically Sign up to receive the latest news and ratings for HSGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSGX vs. The Competition Export to ExcelMetricHistogenicsSurgical Appliances & Supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$65.31M$8.67B$5.25B$7.52BDividend YieldN/A1.71%5.34%4.30%P/E Ratio-0.8718.6821.3617.69Price / SalesN/A68.75366.3293.44Price / CashN/A19.6738.1534.64Price / Book-69.044.736.283.89Net Income-$8.64M$284.66M$3.19B$247.17M Histogenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSGXHistogenicsN/A$0.69+3.1%N/A-60.4%$65.31MN/A-0.8749SMTISanara MedTech1.9758 of 5 stars$27.55-0.9%$48.50+76.0%-11.8%$245.25M$86.67M-27.8360High Trading VolumeINGNInogen2.4753 of 5 stars$7.09+0.7%$7.00-1.3%+0.4%$190.63M$335.71M-3.151,030Analyst ForecastNews CoverageHigh Trading VolumeLAKELakeland Industries4.7612 of 5 stars$16.89-5.4%$28.25+67.3%-4.6%$160.44M$151.82M-187.671,800Earnings ReportAnalyst RevisionNews CoverageAVRAnteris Technologies GlobalN/A$2.90-9.9%$16.50+469.0%N/A$104.47M$2.71M0.00138Positive NewsGap UpZJYLJin Medical InternationalN/A$0.64+4.1%N/A-77.4%$100.49M$23.50M0.00245Positive NewsGap UpMLSSMilestone Scientific1.4612 of 5 stars$0.89+2.3%$1.25+40.4%+57.7%$69.32M$8.88M-12.7130Analyst ForecastGap DownNTRBNutriband2.7753 of 5 stars$5.09-5.7%$13.00+155.4%+9.0%$56.53M$2.02M-7.1710News CoverageGap DownAPTAlpha Pro TechN/A$4.30-1.8%N/A-33.4%$46.75M$57.84M11.62120Options VolumeSPAISafe Pro Group Inc. Common StockN/A$2.35+44.5%N/AN/A$35.65M$2.17M0.0011RBOTVicarious Surgical2.3459 of 5 stars$5.38-3.5%$9.25+72.1%-43.0%$31.88MN/A-0.523News CoverageGap Up Remove Ads Related Companies and Tools Related Companies SMTI Competitors INGN Competitors LAKE Competitors AVR Competitors ZJYL Competitors MLSS Competitors NTRB Competitors APT Competitors SPAI Competitors RBOT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSGX) was last updated on 4/12/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredWARNING to All American InvestorsForget the headlines about the "trade war." This is where a real military showdown between China and the U....Behind the Markets | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for May 7th. Because on that day, I believe we could see a $2 Trillion shock INTO the ma...Timothy Sykes | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Histogenics Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Histogenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HSGX Stock Free HSGX Stock Alerts